November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Bexarotene safe treatment for early-stage CTCL
June 1st 2001Washington - Bexarotene gel appears to be an effective and well-tolerated monotherapy when used as first-line treatment for early-stage cutaneous T-cell lymphoma, Madeleine Duvic, M.D., reported at the annual meeting of the American Academy of Dermatology.
HAART advent shown to improve most dermatologic conditions
June 1st 2001Vancouver, British Columbia - In his 20 years of working with HIV/AIDS patients, Alastair McLeod, M.D., has seen a dramatic change in the incidence and severity of several skin conditions common to the disease. The advent of highly active antiretroviral therapy has eliminated some conditions and greatly improved others, yet other conditions have not shown marked improvement with the drugs.
Fat redistribution treatments remain controversial
June 1st 2001Washington - Among the most hotly debated topics facing dermatologists today is how to address the redistribution of adipose tissue that often occurs in patients with HIV infection. The syndrome, Donald Rudikoff, M.D., told the American Academy of Dermatology audience, is characterized by increased waist-to-hip ratio and central adiposity in 62 percent of patients (Dr. Rudikoff's findings are based on a review of previously published studies). Other manifestations include the appearance of dorsocervical fat pads and loss of fat in areas such as the face, hips, and buttocks, with men being more likely to report fat losses than women.
Expanding field boosts interest in fillers
May 1st 2001Washington - A resurgence of interest in the use of fillers as a minimally invasive cosmetic surgery technique has been accompanied by dramatic growth in the number of products available for soft tissue augmentation, Arnold W. Klein, M.D., said at the annual meeting of the American Academy of Dermatology.